These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. [Kawasaki disease in Italy. 3 new cases]. Scherini A; Vegni M; Elli P; Sangermani R Minerva Pediatr; 1980 Sep; 32(18):1111-6. PubMed ID: 7464751 [No Abstract] [Full Text] [Related]
67. Kawasaki syndrome. Polkowska G Ann Univ Mariae Curie Sklodowska Med; 1994; 49():145-50. PubMed ID: 8771846 [No Abstract] [Full Text] [Related]
68. The profiles of Kawasaki disease in China. Zhang T; Yanagawa H; Nakamura Y J Epidemiol; 2001 May; 11(3):103-8. PubMed ID: 11434420 [TBL] [Abstract][Full Text] [Related]
69. [Effect of gamma globulin therapy judging from color tissue Doppler echocardiography]. Katsube Y; Hajikano M; Ogawa S Nihon Rinsho; 2008 Feb; 66(2):220-3. PubMed ID: 18260318 [No Abstract] [Full Text] [Related]
70. Kawasaki disease, oxygen radicals and high dose gammaglobulin therapy. Kuratsuji T; Shinomiya N; Kobayashi N; Takagi K; Shimizu S; Ojima T; Takahashi E; Hanabusa H Basic Life Sci; 1988; 49():997-1003. PubMed ID: 2471507 [No Abstract] [Full Text] [Related]
71. [Gamma globulins in the therapy of thrombocytopenia]. Chiave P Minerva Pediatr; 1977 May; 29(18):1227-9. PubMed ID: 69256 [No Abstract] [Full Text] [Related]
72. Kawasaki disease and human parvovirus B19 antibody: role of immunoglobulin therapy. Fukushige J; Takahashi N; Ueda K; Okada K; Miyazaki C; Maeda Y Acta Paediatr Jpn; 1995 Dec; 37(6):758-60. PubMed ID: 8775567 [No Abstract] [Full Text] [Related]
73. [Factors in the development of Kawasaki disease and specificity of immunity in children]. Matsuoka Y; Yata J Nihon Rinsho; 1983 Sep; 41(9):2047-51. PubMed ID: 6363750 [No Abstract] [Full Text] [Related]
74. Kawasaki disease associated with streptococcal infection within a family. Anderson DG; Warner G; Barlow E J Paediatr Child Health; 1995 Aug; 31(4):355-7. PubMed ID: 7576898 [TBL] [Abstract][Full Text] [Related]
75. What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada? Rowley AH; Shulman ST Pediatr Infect Dis J; 1988 Jul; 7(7):463-6. PubMed ID: 2457202 [No Abstract] [Full Text] [Related]
76. [Study on the persistence in the circulation of human anti-measles immunoglobulins]. Grillo N; De Filippo P; Tallarino M Pediatria (Napoli); 1975 Mar; 83(1):49-59. PubMed ID: 57596 [No Abstract] [Full Text] [Related]
77. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. Leung DY; Burns JC; Newburger JW; Geha RS J Clin Invest; 1987 Feb; 79(2):468-72. PubMed ID: 2433307 [TBL] [Abstract][Full Text] [Related]
78. Summarizing What Has Been Learned About Kawasaki Disease. Moreno MA JAMA Pediatr; 2016 Nov; 170(11):1124. PubMed ID: 27820626 [No Abstract] [Full Text] [Related]
79. Evaluation of the cytokine response in Kawasaki disease. Eberhard BA; Andersson U; Laxer RM; Rose V; Silverman ED Pediatr Infect Dis J; 1995 Mar; 14(3):199-203. PubMed ID: 7539120 [TBL] [Abstract][Full Text] [Related]
80. The heart and conduction system in acute Kawasaki disease: report of fraternal cases--one lethal, one relapsing. Bharati S; Engle MA; Fatica NS; Bussell JB; Sulayman RF; Lev M; Lynfield J Am Heart J; 1990 Aug; 120(2):359-65. PubMed ID: 1696427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]